{"id":"https://openalex.org/W2969920880","doi":"https://doi.org/10.1080/13696998.2019.1658591","title":"Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma","display_name":"Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma","alternate_titles":[],"publication_year":2019,"publication_date":"2019-08-21","ids":{"openalex":"https://openalex.org/W2969920880","doi":"https://doi.org/10.1080/13696998.2019.1658591","mag":"2969920880","pmid":"https://pubmed.ncbi.nlm.nih.gov/31433700"},"language":"en","primary_location":{"id":"doi:10.1080/13696998.2019.1658591","doi":"https://doi.org/10.1080/13696998.2019.1658591","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13696998.2019.1658591","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2969920880"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1080/13696998.2019.1658591","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049387929","display_name":"Ali McBride","orcid":"https://orcid.org/0000-0002-9430-4675","observed_orcids":["https://orcid.org/0000-0002-9430-4675"]},"institutions":[{"id":"https://openalex.org/I4210124665","display_name":"Banner - University Medical Center Tucson","ror":"https://ror.org/02xbk5j62","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124665"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ali McBride","raw_affiliation_strings":["Banner University Medical Center, Tucson, AZ, USA;","University of Arizona Cancer Center, Tucson, AZ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Banner University Medical Center, Tucson, AZ, USA;","institution_ids":["https://openalex.org/I4210124665"]},{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, AZ, USA;","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008879062","display_name":"Andriy Krendyukov","orcid":"https://orcid.org/0000-0001-8557-1520","observed_orcids":["https://orcid.org/0000-0001-8557-1520"]},"institutions":[{"id":"https://openalex.org/I4210090224","display_name":"Hexal (Germany)","ror":"https://ror.org/00abnnq69","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210090224"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andriy Krendyukov","raw_affiliation_strings":["Hexal AG, Holzkirchen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hexal AG, Holzkirchen, Germany;","institution_ids":["https://openalex.org/I4210090224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113374568","display_name":"Nicola Mathieson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090224","display_name":"Hexal (Germany)","ror":"https://ror.org/00abnnq69","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210090224"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicola Mathieson","raw_affiliation_strings":["Hexal AG, Holzkirchen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hexal AG, Holzkirchen, Germany;","institution_ids":["https://openalex.org/I4210090224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103091434","display_name":"Kim Campbell","orcid":"https://orcid.org/0000-0003-3789-416X","observed_orcids":["https://orcid.org/0000-0003-3789-416X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Campbell","raw_affiliation_strings":["Sandoz, Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandoz, Princeton, NJ, USA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109425197","display_name":"Sanjeev Balu","orcid":"https://orcid.org/0009-0007-1957-3692","observed_orcids":["https://orcid.org/0009-0007-1957-3692"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjeev Balu","raw_affiliation_strings":["Sandoz, Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandoz, Princeton, NJ, USA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036627597","display_name":"Maja Natek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090224","display_name":"Hexal (Germany)","ror":"https://ror.org/00abnnq69","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210090224"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Maja Natek","raw_affiliation_strings":["Hexal AG, Holzkirchen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hexal AG, Holzkirchen, Germany;","institution_ids":["https://openalex.org/I4210090224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090261710","display_name":"Karen MacDonald","orcid":"https://orcid.org/0000-0002-4568-9783","observed_orcids":["https://orcid.org/0000-0002-4568-9783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen MacDonald","raw_affiliation_strings":["Matrix45, Tucson, AZ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Matrix45, Tucson, AZ, USA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108727792","display_name":"Ivo L Abraham","orcid":"https://orcid.org/0000-0003-0490-4421","observed_orcids":["https://orcid.org/0000-0003-0490-4421"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ivo Abraham","raw_affiliation_strings":["Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;","Colleges of Pharmacy and Medicine, University of Arizona, Tucson, AZ, USA","Matrix45, Tucson, AZ, USA;","University of Arizona Cancer Center, Tucson, AZ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Colleges of Pharmacy and Medicine, University of Arizona, Tucson, AZ, USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Matrix45, Tucson, AZ, USA;","institution_ids":[]},{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, AZ, USA;","institution_ids":["https://openalex.org/I4390039223"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5108727792"],"corresponding_institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"],"apc_list":null,"apc_paid":null,"fwci":1.3012,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.80441026,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"23","issue":"1","first_page":"28","last_page":"36"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.8859999775886536},{"id":"https://openalex.org/keywords/on-body-injector","display_name":"on-body injector","score":0.8209999799728394},{"id":"https://openalex.org/keywords/device-failure","display_name":"device failure","score":0.7760000228881836},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.7480000257492065},{"id":"https://openalex.org/keywords/neutropenia-prophylaxis","display_name":"neutropenia prophylaxis","score":0.746999979019165},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.7210000157356262},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":1.0},{"id":"https://openalex.org/keywords/incremental-cost","display_name":"incremental cost","score":0.5799999833106995},{"id":"https://openalex.org/keywords/cost-simulation","display_name":"cost simulation","score":0.7080000042915344},{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.5569999814033508},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.6309999823570251},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C2778658803","wikidata":"https://www.wikidata.org/wiki/Q1592932","display_name":"Pegfilgrastim","level":5,"score":0.9845132827758789},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9317182302474976},{"id":"https://openalex.org/C2779171977","wikidata":"https://www.wikidata.org/wiki/Q3151081","display_name":"Filgrastim","level":4,"score":0.9174363017082214},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.6631518602371216},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.5535321235656738},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5046066045761108},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4974975883960724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45882749557495117},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4395974576473236},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3923061490058899},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3657039999961853}],"mesh":[{"descriptor_ui":"D000069585","descriptor_name":"Filgrastim","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069585","descriptor_name":"Filgrastim","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004868","descriptor_name":"Equipment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011306","descriptor_name":"Prescription Fees","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D064147","descriptor_name":"Febrile Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D064147","descriptor_name":"Febrile Neutropenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/13696998.2019.1658591","doi":"https://doi.org/10.1080/13696998.2019.1658591","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13696998.2019.1658591","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},{"id":"pmid:31433700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31433700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical economics","raw_type":"Journal Article"},{"id":"pmh:oai:repository.arizona.edu:10150/635363","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10150/635363","pdf_url":null,"source":{"id":"https://openalex.org/S4306400271","display_name":"UA Campus Repository (The University of Arizona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138006243","host_organization_name":"University of Arizona","host_organization_lineage":["https://openalex.org/I138006243"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of medical economics","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1080/13696998.2019.1658591","doi":"https://doi.org/10.1080/13696998.2019.1658591","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13696998.2019.1658591","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1751328374","https://openalex.org/W1969840975","https://openalex.org/W1971078174","https://openalex.org/W1973935677","https://openalex.org/W1993608325","https://openalex.org/W2024933507","https://openalex.org/W2029054762","https://openalex.org/W2043370767","https://openalex.org/W2050181011","https://openalex.org/W2059070026","https://openalex.org/W2096288062","https://openalex.org/W2100082529","https://openalex.org/W2104488338","https://openalex.org/W2110645520","https://openalex.org/W2115170812","https://openalex.org/W2120388840","https://openalex.org/W2122038099","https://openalex.org/W2122658272","https://openalex.org/W2124709079","https://openalex.org/W2136733759","https://openalex.org/W2152792488","https://openalex.org/W2169403306","https://openalex.org/W2341557816","https://openalex.org/W2543518004","https://openalex.org/W2546818462","https://openalex.org/W2580390950","https://openalex.org/W2581169234","https://openalex.org/W2610097533","https://openalex.org/W2771411730","https://openalex.org/W2890858376","https://openalex.org/W4249604018"],"related_works":["https://openalex.org/W2907448667","https://openalex.org/W2901177726","https://openalex.org/W3155301493","https://openalex.org/W3159899516","https://openalex.org/W3095833528","https://openalex.org/W4283259835","https://openalex.org/W2737000731","https://openalex.org/W2972496359","https://openalex.org/W2502871527","https://openalex.org/W2735044683"],"abstract_inverted_index":{"Background:":[0],"Guidelines":[1],"recommend":[2],"febrile":[3],"neutropenia":[4],"(FN)":[5],"prophylaxis":[6,77,86,103,113,184,252,272],"following":[7],"myelotoxic":[8],"chemotherapy":[9,118],"with":[10,75,87,104,126,130,142,253],"either":[11],"daily":[12,88],"injections":[13,89,156],"of":[14,66,90,98,109,117,123,182,239],"filgrastim":[15,91,195,213,228],"(Neupogen\u00ae)":[16],"or":[17,24,92,94,137,144],"biosimilar":[18,259],"filgrastim-sndz":[19,93,260,275],"(Zarzio/Zarxio\u00ae),":[20],"single-injection":[21],"pegfilgrastim":[22,25],"(Neulasta\u00ae),":[23],"administered":[26],"through":[27],"an":[28],"on-body":[29],"injector":[30],"(PEG-OBI;":[31],"Neulasta\u00ae":[32],"Onpro\u00ae).":[33],"PEG-OBI":[34,76,105,183,244,265],"failure":[35,81,107,187,245,266],"rates":[36,82,108,188],"up":[37],"to":[38,56,243,250],"6.9%":[39],"have":[40],"been":[41],"reported,":[42],"putting":[43],"patients":[44,125],"at":[45,78,106,185],"incremental":[46,64,72,180,207,222,237],"risk":[47],"for":[48,121,157,165],"FN":[49,67,85],"and":[50,69,133,154,160,163,189,196,214,229,258,268],"FN-related":[51,240],"hospitalization.":[52],"Our":[53],"objective":[54],"was":[55],"estimate,":[57],"from":[58,170,192,210,225],"a":[59,95],"US":[60,172],"payer":[61,173],"perspective,":[62],"the":[63,70,171,178,205,221,236,264,269,277],"costs":[65,73,208,223,238],"hospitalizations":[68],"total":[71,179,206],"associated":[74],"varying":[79,186],"device":[80],"over":[83,194,198,212,216,227,231],"assured":[84,112,251],"single":[96],"injection":[97,149],"pegfilgrastim.Methods:":[99],"Cost":[100],"simulations":[101],"comparing":[102],"1\u201310%":[110],"versus":[111],"in":[114,202,218,246],"cycle":[115,247],"1":[116,248],"were":[119,151],"performed":[120],"panels":[122],"10,000":[124],"lung":[127,158,176],"cancer":[128,159],"treated":[129,141],"cyclophosphamide,":[131],"doxorubicin,":[132],"etoposide":[134],"(1":[135],"analysis)":[136],"non-Hodgkin":[138],"lymphoma":[139],"(NHL)":[140],"CHOP":[143],"CNOP":[145],"(2":[146],"analyses).":[147],"Daily":[148],"scenarios":[150],"4.3,":[152],"5,":[153,161],"11":[155,164],"6.5,":[162],"NHL.":[166],"The":[167],"analyses":[168],"are":[169],"perspective.Results:":[174],"For":[175,200],"cancer,":[177],"cost":[181],"durations":[190],"ranged":[191,209,224],"$6,691,969\u2012$31,765,299":[193],"$18,901,969\u2012$36,538,299":[197],"filgrastim-sndz.":[199],"NHL,":[201],"scenario":[203,219],"1,":[204],"$6,794,984\u2012$30,361,345":[211],"$19,004,984\u2012$35,911,345":[215],"filgrastim-sndz;":[217],"2,":[220],"$7,003,657\u2012$32,448,067":[226],"$19,213,657\u2012$37,998,067":[230],"filgrastim-sndz.Conclusions:":[232],"In":[233],"this":[234],"simulation,":[235],"hospitalization":[241],"due":[242],"compared":[249],"reference":[254,256],"pegfilgrastim,":[255],"filgrastim,":[257],"varied":[261],"depending":[262],"upon":[263],"rate":[267],"alternative":[270],"G-CSF":[271],"option.":[273],"Biosimilar":[274],"offers":[276],"greatest":[278],"cost-efficiency.":[279]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2969920880","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-08-29T00:00:00"}
